US equities |
INTC $65.89 ▼-28.44% AMZN $235.70 ▼-3.32% MU $888.62 ▼-4.89% NVDA $206.54 ▼-3.33% SNDK $1,194.96 ▼-10.16% GOOGL $279.96 ▼-1.36% AMD $510.96 ▼-9.79% TSLA $397.38 ▼-1.47%
FinancialContent

CDT Equity Inc. - Common Stock (NQ:CDT)

0.0681 -0.0089 (-11.56%)
Delayed Quote Updated: 10:21 AM EDT, Oct 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about CDT Equity Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
CDT Equity Welcomes U.S. Regulatory Development Supporting Expanded Access to Compounded Peptides
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Partners with Manoira to Explore Enhancing Animal Health Products Ahead of Launch
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Highlights Sarborg's Solid-Form Patent Filing on a First-in-Class Respiratory Asset
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Highlights Sarborg’s Expanding Quantum Computing IP Portfolio and Application to Drug Discovery
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Equity Inc. Announces Reverse Stock Split
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Partners with QIMA Life Sciences to Evaluate Novel Tapinarof Combinations in Psoriasis and Vitiligo
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Highlights Sarborg’s Application of Signature Intelligence and Quantum Computing Models to Mental Health
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Provides Capital Update and Confirms No Nasdaq Deficiencies
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Appoints Co-Founder James Bligh as Chief Executive Officer to Lead Next Phase of Growth
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Announces Investment in Pep'd, Expanding into the Fast-Growing US Peptide Market
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Increases Stake in Sarborg following its Quantum Computing and Intellectual Property Expansion
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Highlights Sarborg's Patent Filing Extending Quantum-Enabled PRISM Platform to Sugarcane
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Equity Inc. Announces Reverse Stock Split
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Highlights Sarborg's Application of Quantum Computing to Solid-Form Development
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Notes Strategic Investment into Sarborg and Expansion into Quantum Computing
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Equity Announces Debt Update and New Loan Facility
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Announces Canadian Patent for AZD5904 in Male Infertility
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Notes Sarborg Publication of PRISM Framework Expanding AI
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Equity Inc. Announces Reverse Stock Split
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent
From CDT Equity Inc.
Via GlobeNewswire
News headline image
CDT Positions for Transformational Growth
From CDT Equity Inc.
Via GlobeNewswire
< Previous 1 2 3 Next >